Magnesium sulphate injection administration
| Indication | Notes |
|---|---|
| Eclampsia / Seizure treatment | First-line anticonvulsant |
| Preeclampsia with severe features | Seizure prophylaxis (intrapartum + ≥24 hrs postpartum) |
| Torsades de pointes / polymorphic VT | Antiarrhythmic (inhibits calcium currents) |
| Fetal neuroprotection | Given before delivery <32 weeks' gestation |
| Hypomagnesaemia | Replacement therapy |
In renal insufficiency (creatinine >1 mg/dL): reduce bolus to 2 g IV, then obtain serum magnesium level before increasing infusion rate - Tintinalli's Emergency Medicine
| Effect | Serum Level (mEq/L) |
|---|---|
| Therapeutic anticonvulsant range | 4.8 - 8.4 |
| Loss of deep tendon reflexes (DTR) | 7 - 10 |
| Respiratory paralysis | 10 - 13 |
| ECG changes | >15 |
| Cardiac arrest | >25 |
Presence of deep tendon reflexes = serum magnesium is NOT dangerously high. Loss of DTR = first clinical warning sign of toxicity. - Creasy & Resnik's Maternal-Fetal Medicine
| Antidote | Dose | Notes |
|---|---|---|
| Calcium gluconate 10% | 1 g IV slowly (over 3-5 min) | Directly reverses respiratory and cardiac toxicity |
| Oxygen + ventilatory support | As needed | For respiratory depression |